Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib dose escalation in advanced HCC
NCT00490685Phase 2Completed
- Sponsor
- Humanitas Research Hospital
- Start
- Apr 2007
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in hepatocellular carcinoma (HCC), sponsored by Humanitas Research Hospital. Started Apr 2007; status: completed.
02
Drugs
sorafenib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00490685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00490685.